nodes	percent_of_prediction	percent_of_DWPC	metapath
Midazolam—CYP3A5—Sulfasalazine—ankylosing spondylitis	0.0782	0.108	CbGbCtD
Midazolam—ABCB1—Methylprednisolone—ankylosing spondylitis	0.0672	0.0928	CbGbCtD
Midazolam—CYP3A7-CYP3A51P—Dexamethasone—ankylosing spondylitis	0.0521	0.0719	CbGbCtD
Midazolam—CYP3A7—Dexamethasone—ankylosing spondylitis	0.0521	0.0719	CbGbCtD
Midazolam—CYP2E1—Dexamethasone—ankylosing spondylitis	0.0503	0.0694	CbGbCtD
Midazolam—CYP2B6—Dexamethasone—ankylosing spondylitis	0.0496	0.0685	CbGbCtD
Midazolam—ABCB1—Betamethasone—ankylosing spondylitis	0.0437	0.0603	CbGbCtD
Midazolam—ABCB1—Prednisolone—ankylosing spondylitis	0.0431	0.0595	CbGbCtD
Midazolam—ABCB1—Prednisone—ankylosing spondylitis	0.0407	0.0562	CbGbCtD
Midazolam—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0403	0.0556	CbGbCtD
Midazolam—CYP3A5—Dexamethasone—ankylosing spondylitis	0.0391	0.0539	CbGbCtD
Midazolam—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0305	0.0421	CbGbCtD
Midazolam—CYP3A4—Betamethasone—ankylosing spondylitis	0.0262	0.0362	CbGbCtD
Midazolam—CYP3A4—Prednisolone—ankylosing spondylitis	0.0258	0.0357	CbGbCtD
Midazolam—ABCB1—Dexamethasone—ankylosing spondylitis	0.0254	0.0351	CbGbCtD
Midazolam—CYP3A4—Prednisone—ankylosing spondylitis	0.0244	0.0337	CbGbCtD
Midazolam—ABCB1—Methotrexate—ankylosing spondylitis	0.0204	0.0282	CbGbCtD
Midazolam—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0152	0.021	CbGbCtD
Midazolam—GABRQ—Orphan transporters—ANO6—ankylosing spondylitis	0.00101	0.0472	CbGpPWpGaD
Midazolam—Thrombophlebitis—Prednisone—ankylosing spondylitis	0.000896	0.00352	CcSEcCtD
Midazolam—Osteoarthritis—Dexamethasone—ankylosing spondylitis	0.000891	0.0035	CcSEcCtD
Midazolam—Osteoarthritis—Betamethasone—ankylosing spondylitis	0.000891	0.0035	CcSEcCtD
Midazolam—Affect lability—Dexamethasone—ankylosing spondylitis	0.000877	0.00345	CcSEcCtD
Midazolam—Affect lability—Betamethasone—ankylosing spondylitis	0.000877	0.00345	CcSEcCtD
Midazolam—Psychotic disorder—Dexamethasone—ankylosing spondylitis	0.00087	0.00342	CcSEcCtD
Midazolam—Psychotic disorder—Betamethasone—ankylosing spondylitis	0.00087	0.00342	CcSEcCtD
Midazolam—Muscular weakness—Triamcinolone—ankylosing spondylitis	0.000866	0.0034	CcSEcCtD
Midazolam—Muscular weakness—Methylprednisolone—ankylosing spondylitis	0.000864	0.00339	CcSEcCtD
Midazolam—Depressed level of consciousness—Methotrexate—ankylosing spondylitis	0.000862	0.00339	CcSEcCtD
Midazolam—Skin exfoliation—Methotrexate—ankylosing spondylitis	0.000852	0.00335	CcSEcCtD
Midazolam—Irritability—Betamethasone—ankylosing spondylitis	0.00085	0.00334	CcSEcCtD
Midazolam—Irritability—Dexamethasone—ankylosing spondylitis	0.00085	0.00334	CcSEcCtD
Midazolam—Cardiac arrest—Dexamethasone—ankylosing spondylitis	0.000847	0.00333	CcSEcCtD
Midazolam—Cardiac arrest—Betamethasone—ankylosing spondylitis	0.000847	0.00333	CcSEcCtD
Midazolam—Injury—Prednisone—ankylosing spondylitis	0.000844	0.00332	CcSEcCtD
Midazolam—Mood swings—Dexamethasone—ankylosing spondylitis	0.000844	0.00332	CcSEcCtD
Midazolam—Mood swings—Betamethasone—ankylosing spondylitis	0.000844	0.00332	CcSEcCtD
Midazolam—GABRG3—Orphan transporters—ANO6—ankylosing spondylitis	0.000834	0.0389	CbGpPWpGaD
Midazolam—Bronchospasm—Methylprednisolone—ankylosing spondylitis	0.000833	0.00327	CcSEcCtD
Midazolam—GABRB1—Orphan transporters—ANO6—ankylosing spondylitis	0.000821	0.0383	CbGpPWpGaD
Midazolam—Neuropathy peripheral—Prednisolone—ankylosing spondylitis	0.000806	0.00317	CcSEcCtD
Midazolam—Cardiac failure—Prednisone—ankylosing spondylitis	0.000795	0.00312	CcSEcCtD
Midazolam—Lethargy—Prednisone—ankylosing spondylitis	0.000791	0.00311	CcSEcCtD
Midazolam—Muscular weakness—Betamethasone—ankylosing spondylitis	0.000785	0.00309	CcSEcCtD
Midazolam—Muscular weakness—Dexamethasone—ankylosing spondylitis	0.000785	0.00309	CcSEcCtD
Midazolam—GABRA6—Orphan transporters—ANO6—ankylosing spondylitis	0.000777	0.0363	CbGpPWpGaD
Midazolam—Osteoarthritis—Prednisone—ankylosing spondylitis	0.000776	0.00305	CcSEcCtD
Midazolam—GABRA4—Orphan transporters—ANO6—ankylosing spondylitis	0.000767	0.0358	CbGpPWpGaD
Midazolam—Affect lability—Prednisone—ankylosing spondylitis	0.000763	0.003	CcSEcCtD
Midazolam—Psychotic disorder—Prednisone—ankylosing spondylitis	0.000757	0.00298	CcSEcCtD
Midazolam—Bradycardia—Prednisolone—ankylosing spondylitis	0.000752	0.00295	CcSEcCtD
Midazolam—Thrombophlebitis—Methotrexate—ankylosing spondylitis	0.000749	0.00294	CcSEcCtD
Midazolam—GABRR1—Ion channel transport—ANO6—ankylosing spondylitis	0.000744	0.0347	CbGpPWpGaD
Midazolam—Neuropathy peripheral—Triamcinolone—ankylosing spondylitis	0.000741	0.00291	CcSEcCtD
Midazolam—Irritability—Prednisone—ankylosing spondylitis	0.00074	0.00291	CcSEcCtD
Midazolam—Neuropathy peripheral—Methylprednisolone—ankylosing spondylitis	0.00074	0.00291	CcSEcCtD
Midazolam—Cardiac arrest—Prednisone—ankylosing spondylitis	0.000737	0.0029	CcSEcCtD
Midazolam—Mood swings—Prednisone—ankylosing spondylitis	0.000735	0.00289	CcSEcCtD
Midazolam—Visual impairment—Prednisolone—ankylosing spondylitis	0.000712	0.0028	CcSEcCtD
Midazolam—GABRR2—Ion channel transport—ANO6—ankylosing spondylitis	0.00071	0.0331	CbGpPWpGaD
Midazolam—GABRQ—Ion channel transport—ANO6—ankylosing spondylitis	0.00071	0.0331	CbGpPWpGaD
Midazolam—GABRB2—Orphan transporters—ANO6—ankylosing spondylitis	0.000702	0.0327	CbGpPWpGaD
Midazolam—Bradycardia—Triamcinolone—ankylosing spondylitis	0.000691	0.00272	CcSEcCtD
Midazolam—Bradycardia—Methylprednisolone—ankylosing spondylitis	0.00069	0.00271	CcSEcCtD
Midazolam—Muscular weakness—Prednisone—ankylosing spondylitis	0.000684	0.00269	CcSEcCtD
Midazolam—Visual disturbance—Methotrexate—ankylosing spondylitis	0.000684	0.00269	CcSEcCtD
Midazolam—GABRA5—Orphan transporters—ANO6—ankylosing spondylitis	0.000682	0.0318	CbGpPWpGaD
Midazolam—Hallucination—Methylprednisolone—ankylosing spondylitis	0.000674	0.00265	CcSEcCtD
Midazolam—Neuropathy peripheral—Betamethasone—ankylosing spondylitis	0.000673	0.00264	CcSEcCtD
Midazolam—Neuropathy peripheral—Dexamethasone—ankylosing spondylitis	0.000673	0.00264	CcSEcCtD
Midazolam—Anaphylactoid reaction—Methotrexate—ankylosing spondylitis	0.00067	0.00263	CcSEcCtD
Midazolam—GABRA3—Orphan transporters—ANO6—ankylosing spondylitis	0.000669	0.0312	CbGpPWpGaD
Midazolam—Connective tissue disorder—Methylprednisolone—ankylosing spondylitis	0.000666	0.00262	CcSEcCtD
Midazolam—Lethargy—Methotrexate—ankylosing spondylitis	0.000661	0.0026	CcSEcCtD
Midazolam—GABRA2—Orphan transporters—ANO6—ankylosing spondylitis	0.000658	0.0307	CbGpPWpGaD
Midazolam—GABRB3—Orphan transporters—ANO6—ankylosing spondylitis	0.000654	0.0305	CbGpPWpGaD
Midazolam—Visual impairment—Methylprednisolone—ankylosing spondylitis	0.000653	0.00257	CcSEcCtD
Midazolam—Osteoarthritis—Methotrexate—ankylosing spondylitis	0.000648	0.00255	CcSEcCtD
Midazolam—Erythema—Prednisolone—ankylosing spondylitis	0.000643	0.00253	CcSEcCtD
Midazolam—GABRG2—Orphan transporters—ANO6—ankylosing spondylitis	0.000642	0.03	CbGpPWpGaD
Midazolam—Eye disorder—Methylprednisolone—ankylosing spondylitis	0.000633	0.00249	CcSEcCtD
Midazolam—Cardiac disorder—Methylprednisolone—ankylosing spondylitis	0.000629	0.00247	CcSEcCtD
Midazolam—Bradycardia—Betamethasone—ankylosing spondylitis	0.000627	0.00247	CcSEcCtD
Midazolam—Bradycardia—Dexamethasone—ankylosing spondylitis	0.000627	0.00247	CcSEcCtD
Midazolam—Irritability—Methotrexate—ankylosing spondylitis	0.000619	0.00243	CcSEcCtD
Midazolam—Mood swings—Methotrexate—ankylosing spondylitis	0.000614	0.00241	CcSEcCtD
Midazolam—Hallucination—Dexamethasone—ankylosing spondylitis	0.000613	0.00241	CcSEcCtD
Midazolam—Hallucination—Betamethasone—ankylosing spondylitis	0.000613	0.00241	CcSEcCtD
Midazolam—Immune system disorder—Methylprednisolone—ankylosing spondylitis	0.000612	0.00241	CcSEcCtD
Midazolam—Mediastinal disorder—Methylprednisolone—ankylosing spondylitis	0.000611	0.0024	CcSEcCtD
Midazolam—Ataxia—Methotrexate—ankylosing spondylitis	0.000609	0.0024	CcSEcCtD
Midazolam—Vision blurred—Prednisolone—ankylosing spondylitis	0.000606	0.00238	CcSEcCtD
Midazolam—Depression—Prednisone—ankylosing spondylitis	0.000596	0.00234	CcSEcCtD
Midazolam—Visual impairment—Betamethasone—ankylosing spondylitis	0.000594	0.00233	CcSEcCtD
Midazolam—Visual impairment—Dexamethasone—ankylosing spondylitis	0.000594	0.00233	CcSEcCtD
Midazolam—Mental disorder—Methylprednisolone—ankylosing spondylitis	0.000594	0.00233	CcSEcCtD
Midazolam—Erythema—Triamcinolone—ankylosing spondylitis	0.000591	0.00232	CcSEcCtD
Midazolam—Erythema—Methylprednisolone—ankylosing spondylitis	0.00059	0.00232	CcSEcCtD
Midazolam—Neuropathy peripheral—Prednisone—ankylosing spondylitis	0.000586	0.0023	CcSEcCtD
Midazolam—GABRG3—Ion channel transport—ANO6—ankylosing spondylitis	0.000585	0.0273	CbGpPWpGaD
Midazolam—Vertigo—Prednisolone—ankylosing spondylitis	0.000577	0.00227	CcSEcCtD
Midazolam—Syncope—Prednisolone—ankylosing spondylitis	0.000576	0.00227	CcSEcCtD
Midazolam—GABRB1—Ion channel transport—ANO6—ankylosing spondylitis	0.000576	0.0269	CbGpPWpGaD
Midazolam—Eye disorder—Betamethasone—ankylosing spondylitis	0.000576	0.00226	CcSEcCtD
Midazolam—Eye disorder—Dexamethasone—ankylosing spondylitis	0.000576	0.00226	CcSEcCtD
Midazolam—UGT1A4—Aryl Hydrocarbon Receptor Pathway—IL12B—ankylosing spondylitis	0.000575	0.0268	CbGpPWpGaD
Midazolam—GABRA1—Orphan transporters—ANO6—ankylosing spondylitis	0.000561	0.0262	CbGpPWpGaD
Midazolam—Bradycardia—Prednisone—ankylosing spondylitis	0.000546	0.00215	CcSEcCtD
Midazolam—GABRA6—Ion channel transport—ANO6—ankylosing spondylitis	0.000545	0.0254	CbGpPWpGaD
Midazolam—GABRA4—Ion channel transport—ANO6—ankylosing spondylitis	0.000538	0.0251	CbGpPWpGaD
Midazolam—Erythema—Betamethasone—ankylosing spondylitis	0.000536	0.00211	CcSEcCtD
Midazolam—Erythema—Dexamethasone—ankylosing spondylitis	0.000536	0.00211	CcSEcCtD
Midazolam—Hallucination—Prednisone—ankylosing spondylitis	0.000534	0.0021	CcSEcCtD
Midazolam—Vertigo—Triamcinolone—ankylosing spondylitis	0.000531	0.00209	CcSEcCtD
Midazolam—Syncope—Triamcinolone—ankylosing spondylitis	0.00053	0.00208	CcSEcCtD
Midazolam—Vertigo—Methylprednisolone—ankylosing spondylitis	0.00053	0.00208	CcSEcCtD
Midazolam—Syncope—Methylprednisolone—ankylosing spondylitis	0.000529	0.00208	CcSEcCtD
Midazolam—Connective tissue disorder—Prednisone—ankylosing spondylitis	0.000527	0.00207	CcSEcCtD
Midazolam—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.000525	0.00206	CcSEcCtD
Midazolam—Shock—Prednisolone—ankylosing spondylitis	0.000516	0.00203	CcSEcCtD
Midazolam—Cough—Triamcinolone—ankylosing spondylitis	0.000516	0.00203	CcSEcCtD
Midazolam—Tachycardia—Prednisolone—ankylosing spondylitis	0.000512	0.00201	CcSEcCtD
Midazolam—Eye disorder—Prednisone—ankylosing spondylitis	0.000501	0.00197	CcSEcCtD
Midazolam—Anxiety—Methylprednisolone—ankylosing spondylitis	0.0005	0.00197	CcSEcCtD
Midazolam—Drowsiness—Methotrexate—ankylosing spondylitis	0.000499	0.00196	CcSEcCtD
Midazolam—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.000499	0.00196	CcSEcCtD
Midazolam—Depression—Methotrexate—ankylosing spondylitis	0.000498	0.00196	CcSEcCtD
Midazolam—GABRB2—Ion channel transport—ANO6—ankylosing spondylitis	0.000492	0.023	CbGpPWpGaD
Midazolam—Dry mouth—Triamcinolone—ankylosing spondylitis	0.000492	0.00193	CcSEcCtD
Midazolam—Confusional state—Methylprednisolone—ankylosing spondylitis	0.000485	0.00191	CcSEcCtD
Midazolam—Immune system disorder—Prednisone—ankylosing spondylitis	0.000485	0.0019	CcSEcCtD
Midazolam—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.000482	0.0019	CcSEcCtD
Midazolam—Vertigo—Betamethasone—ankylosing spondylitis	0.000482	0.00189	CcSEcCtD
Midazolam—Vertigo—Dexamethasone—ankylosing spondylitis	0.000482	0.00189	CcSEcCtD
Midazolam—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.000481	0.00189	CcSEcCtD
Midazolam—Syncope—Dexamethasone—ankylosing spondylitis	0.000481	0.00189	CcSEcCtD
Midazolam—Syncope—Betamethasone—ankylosing spondylitis	0.000481	0.00189	CcSEcCtD
Midazolam—GABRA5—Ion channel transport—ANO6—ankylosing spondylitis	0.000478	0.0223	CbGpPWpGaD
Midazolam—Shock—Triamcinolone—ankylosing spondylitis	0.000475	0.00187	CcSEcCtD
Midazolam—Shock—Methylprednisolone—ankylosing spondylitis	0.000474	0.00186	CcSEcCtD
Midazolam—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000472	0.00186	CcSEcCtD
Midazolam—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000471	0.00185	CcSEcCtD
Midazolam—Tachycardia—Triamcinolone—ankylosing spondylitis	0.000471	0.00185	CcSEcCtD
Midazolam—Mental disorder—Prednisone—ankylosing spondylitis	0.00047	0.00185	CcSEcCtD
Midazolam—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.00047	0.00185	CcSEcCtD
Midazolam—GABRA3—Ion channel transport—ANO6—ankylosing spondylitis	0.00047	0.0219	CbGpPWpGaD
Midazolam—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000468	0.00184	CcSEcCtD
Midazolam—Erythema—Prednisone—ankylosing spondylitis	0.000467	0.00184	CcSEcCtD
Midazolam—GABRA2—Ion channel transport—ANO6—ankylosing spondylitis	0.000461	0.0215	CbGpPWpGaD
Midazolam—GABRB3—Ion channel transport—ANO6—ankylosing spondylitis	0.000458	0.0214	CbGpPWpGaD
Midazolam—Anxiety—Dexamethasone—ankylosing spondylitis	0.000455	0.00179	CcSEcCtD
Midazolam—Anxiety—Betamethasone—ankylosing spondylitis	0.000455	0.00179	CcSEcCtD
Midazolam—GABRG2—Ion channel transport—ANO6—ankylosing spondylitis	0.00045	0.021	CbGpPWpGaD
Midazolam—Hypotension—Methylprednisolone—ankylosing spondylitis	0.00045	0.00177	CcSEcCtD
Midazolam—Pain—Prednisolone—ankylosing spondylitis	0.000449	0.00176	CcSEcCtD
Midazolam—Vision blurred—Prednisone—ankylosing spondylitis	0.00044	0.00173	CcSEcCtD
Midazolam—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.000438	0.00172	CcSEcCtD
Midazolam—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.000438	0.00172	CcSEcCtD
Midazolam—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000433	0.0017	CcSEcCtD
Midazolam—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000432	0.0017	CcSEcCtD
Midazolam—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000432	0.0017	CcSEcCtD
Midazolam—Visual impairment—Methotrexate—ankylosing spondylitis	0.000432	0.0017	CcSEcCtD
Midazolam—Shock—Dexamethasone—ankylosing spondylitis	0.000431	0.00169	CcSEcCtD
Midazolam—Shock—Betamethasone—ankylosing spondylitis	0.000431	0.00169	CcSEcCtD
Midazolam—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.00043	0.00169	CcSEcCtD
Midazolam—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000429	0.00169	CcSEcCtD
Midazolam—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000429	0.00169	CcSEcCtD
Midazolam—Agitation—Prednisone—ankylosing spondylitis	0.000429	0.00169	CcSEcCtD
Midazolam—Tachycardia—Dexamethasone—ankylosing spondylitis	0.000427	0.00168	CcSEcCtD
Midazolam—Tachycardia—Betamethasone—ankylosing spondylitis	0.000427	0.00168	CcSEcCtD
Midazolam—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000425	0.00167	CcSEcCtD
Midazolam—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000424	0.00167	CcSEcCtD
Midazolam—Vertigo—Prednisone—ankylosing spondylitis	0.00042	0.00165	CcSEcCtD
Midazolam—Eye disorder—Methotrexate—ankylosing spondylitis	0.000419	0.00165	CcSEcCtD
Midazolam—Syncope—Prednisone—ankylosing spondylitis	0.000419	0.00165	CcSEcCtD
Midazolam—Urticaria—Prednisolone—ankylosing spondylitis	0.000417	0.00164	CcSEcCtD
Midazolam—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.000416	0.00164	CcSEcCtD
Midazolam—Fatigue—Triamcinolone—ankylosing spondylitis	0.000416	0.00163	CcSEcCtD
Midazolam—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000415	0.00163	CcSEcCtD
Midazolam—Pain—Triamcinolone—ankylosing spondylitis	0.000413	0.00162	CcSEcCtD
Midazolam—Hypotension—Dexamethasone—ankylosing spondylitis	0.000409	0.00161	CcSEcCtD
Midazolam—Hypotension—Betamethasone—ankylosing spondylitis	0.000409	0.00161	CcSEcCtD
Midazolam—Immune system disorder—Methotrexate—ankylosing spondylitis	0.000405	0.00159	CcSEcCtD
Midazolam—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.000404	0.00159	CcSEcCtD
Midazolam—Chills—Methotrexate—ankylosing spondylitis	0.000402	0.00158	CcSEcCtD
Midazolam—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000398	0.00156	CcSEcCtD
Midazolam—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000397	0.00156	CcSEcCtD
Midazolam—Anxiety—Prednisone—ankylosing spondylitis	0.000396	0.00156	CcSEcCtD
Midazolam—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000395	0.00155	CcSEcCtD
Midazolam—GABRA1—Ion channel transport—ANO6—ankylosing spondylitis	0.000393	0.0184	CbGpPWpGaD
Midazolam—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000393	0.00154	CcSEcCtD
Midazolam—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000393	0.00154	CcSEcCtD
Midazolam—Mental disorder—Methotrexate—ankylosing spondylitis	0.000393	0.00154	CcSEcCtD
Midazolam—Erythema—Methotrexate—ankylosing spondylitis	0.00039	0.00153	CcSEcCtD
Midazolam—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000386	0.00152	CcSEcCtD
Midazolam—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000385	0.00151	CcSEcCtD
Midazolam—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000385	0.00151	CcSEcCtD
Midazolam—Urticaria—Triamcinolone—ankylosing spondylitis	0.000383	0.00151	CcSEcCtD
Midazolam—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000382	0.0015	CcSEcCtD
Midazolam—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.000381	0.0015	CcSEcCtD
Midazolam—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000378	0.00149	CcSEcCtD
Midazolam—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000378	0.00149	CcSEcCtD
Midazolam—Fatigue—Betamethasone—ankylosing spondylitis	0.000377	0.00148	CcSEcCtD
Midazolam—Fatigue—Dexamethasone—ankylosing spondylitis	0.000377	0.00148	CcSEcCtD
Midazolam—Shock—Prednisone—ankylosing spondylitis	0.000375	0.00147	CcSEcCtD
Midazolam—Pain—Dexamethasone—ankylosing spondylitis	0.000374	0.00147	CcSEcCtD
Midazolam—Pain—Betamethasone—ankylosing spondylitis	0.000374	0.00147	CcSEcCtD
Midazolam—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000374	0.00147	CcSEcCtD
Midazolam—Tachycardia—Prednisone—ankylosing spondylitis	0.000372	0.00146	CcSEcCtD
Midazolam—Skin disorder—Prednisone—ankylosing spondylitis	0.00037	0.00146	CcSEcCtD
Midazolam—Vision blurred—Methotrexate—ankylosing spondylitis	0.000368	0.00145	CcSEcCtD
Midazolam—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000361	0.00142	CcSEcCtD
Midazolam—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000361	0.00142	CcSEcCtD
Midazolam—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000355	0.0014	CcSEcCtD
Midazolam—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000355	0.00139	CcSEcCtD
Midazolam—Vertigo—Methotrexate—ankylosing spondylitis	0.000351	0.00138	CcSEcCtD
Midazolam—Urticaria—Dexamethasone—ankylosing spondylitis	0.000348	0.00137	CcSEcCtD
Midazolam—Urticaria—Betamethasone—ankylosing spondylitis	0.000348	0.00137	CcSEcCtD
Midazolam—Dizziness—Prednisolone—ankylosing spondylitis	0.000347	0.00136	CcSEcCtD
Midazolam—Asthenia—Triamcinolone—ankylosing spondylitis	0.000346	0.00136	CcSEcCtD
Midazolam—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000345	0.00136	CcSEcCtD
Midazolam—Paraesthesia—Prednisone—ankylosing spondylitis	0.000342	0.00135	CcSEcCtD
Midazolam—Pruritus—Triamcinolone—ankylosing spondylitis	0.000341	0.00134	CcSEcCtD
Midazolam—Cough—Methotrexate—ankylosing spondylitis	0.000341	0.00134	CcSEcCtD
Midazolam—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000341	0.00134	CcSEcCtD
Midazolam—Dyspepsia—Prednisone—ankylosing spondylitis	0.000336	0.00132	CcSEcCtD
Midazolam—Rash—Prednisolone—ankylosing spondylitis	0.000331	0.0013	CcSEcCtD
Midazolam—Dermatitis—Prednisolone—ankylosing spondylitis	0.00033	0.0013	CcSEcCtD
Midazolam—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.00033	0.0013	CcSEcCtD
Midazolam—Fatigue—Prednisone—ankylosing spondylitis	0.000329	0.00129	CcSEcCtD
Midazolam—Headache—Prednisolone—ankylosing spondylitis	0.000329	0.00129	CcSEcCtD
Midazolam—Constipation—Prednisone—ankylosing spondylitis	0.000326	0.00128	CcSEcCtD
Midazolam—Confusional state—Methotrexate—ankylosing spondylitis	0.000321	0.00126	CcSEcCtD
Midazolam—Dizziness—Triamcinolone—ankylosing spondylitis	0.000319	0.00125	CcSEcCtD
Midazolam—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.000319	0.00125	CcSEcCtD
Midazolam—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000318	0.00125	CcSEcCtD
Midazolam—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000314	0.00123	CcSEcCtD
Midazolam—Asthenia—Dexamethasone—ankylosing spondylitis	0.000314	0.00123	CcSEcCtD
Midazolam—Asthenia—Betamethasone—ankylosing spondylitis	0.000314	0.00123	CcSEcCtD
Midazolam—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000312	0.00123	CcSEcCtD
Midazolam—Nausea—Prednisolone—ankylosing spondylitis	0.000312	0.00122	CcSEcCtD
Midazolam—Pruritus—Betamethasone—ankylosing spondylitis	0.00031	0.00122	CcSEcCtD
Midazolam—Pruritus—Dexamethasone—ankylosing spondylitis	0.00031	0.00122	CcSEcCtD
Midazolam—Skin disorder—Methotrexate—ankylosing spondylitis	0.000309	0.00122	CcSEcCtD
Midazolam—Vomiting—Triamcinolone—ankylosing spondylitis	0.000307	0.00121	CcSEcCtD
Midazolam—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000306	0.0012	CcSEcCtD
Midazolam—Rash—Triamcinolone—ankylosing spondylitis	0.000304	0.0012	CcSEcCtD
Midazolam—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000304	0.00119	CcSEcCtD
Midazolam—Rash—Methylprednisolone—ankylosing spondylitis	0.000303	0.00119	CcSEcCtD
Midazolam—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000303	0.00119	CcSEcCtD
Midazolam—Urticaria—Prednisone—ankylosing spondylitis	0.000303	0.00119	CcSEcCtD
Midazolam—Headache—Triamcinolone—ankylosing spondylitis	0.000302	0.00119	CcSEcCtD
Midazolam—Headache—Methylprednisolone—ankylosing spondylitis	0.000302	0.00119	CcSEcCtD
Midazolam—Hypotension—Methotrexate—ankylosing spondylitis	0.000298	0.00117	CcSEcCtD
Midazolam—Dizziness—Dexamethasone—ankylosing spondylitis	0.000289	0.00114	CcSEcCtD
Midazolam—Dizziness—Betamethasone—ankylosing spondylitis	0.000289	0.00114	CcSEcCtD
Midazolam—Nausea—Triamcinolone—ankylosing spondylitis	0.000287	0.00113	CcSEcCtD
Midazolam—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000286	0.00112	CcSEcCtD
Midazolam—Nausea—Methylprednisolone—ankylosing spondylitis	0.000286	0.00112	CcSEcCtD
Midazolam—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000284	0.00112	CcSEcCtD
Midazolam—Somnolence—Methotrexate—ankylosing spondylitis	0.000283	0.00111	CcSEcCtD
Midazolam—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000281	0.0011	CcSEcCtD
Midazolam—Dyspepsia—Methotrexate—ankylosing spondylitis	0.00028	0.0011	CcSEcCtD
Midazolam—Vomiting—Dexamethasone—ankylosing spondylitis	0.000278	0.00109	CcSEcCtD
Midazolam—Vomiting—Betamethasone—ankylosing spondylitis	0.000278	0.00109	CcSEcCtD
Midazolam—Rash—Betamethasone—ankylosing spondylitis	0.000276	0.00108	CcSEcCtD
Midazolam—Rash—Dexamethasone—ankylosing spondylitis	0.000276	0.00108	CcSEcCtD
Midazolam—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000276	0.00108	CcSEcCtD
Midazolam—Dermatitis—Betamethasone—ankylosing spondylitis	0.000276	0.00108	CcSEcCtD
Midazolam—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000275	0.00108	CcSEcCtD
Midazolam—Fatigue—Methotrexate—ankylosing spondylitis	0.000275	0.00108	CcSEcCtD
Midazolam—Headache—Betamethasone—ankylosing spondylitis	0.000274	0.00108	CcSEcCtD
Midazolam—Headache—Dexamethasone—ankylosing spondylitis	0.000274	0.00108	CcSEcCtD
Midazolam—Asthenia—Prednisone—ankylosing spondylitis	0.000273	0.00107	CcSEcCtD
Midazolam—Pain—Methotrexate—ankylosing spondylitis	0.000272	0.00107	CcSEcCtD
Midazolam—Pruritus—Prednisone—ankylosing spondylitis	0.00027	0.00106	CcSEcCtD
Midazolam—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000263	0.00103	CcSEcCtD
Midazolam—Nausea—Dexamethasone—ankylosing spondylitis	0.00026	0.00102	CcSEcCtD
Midazolam—Nausea—Betamethasone—ankylosing spondylitis	0.00026	0.00102	CcSEcCtD
Midazolam—GABRR1—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000259	0.0121	CbGpPWpGaD
Midazolam—Urticaria—Methotrexate—ankylosing spondylitis	0.000253	0.000995	CcSEcCtD
Midazolam—Dizziness—Prednisone—ankylosing spondylitis	0.000252	0.000991	CcSEcCtD
Midazolam—GABRQ—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000247	0.0115	CbGpPWpGaD
Midazolam—GABRR2—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000247	0.0115	CbGpPWpGaD
Midazolam—Vomiting—Prednisone—ankylosing spondylitis	0.000242	0.000953	CcSEcCtD
Midazolam—Rash—Prednisone—ankylosing spondylitis	0.00024	0.000945	CcSEcCtD
Midazolam—Dermatitis—Prednisone—ankylosing spondylitis	0.00024	0.000944	CcSEcCtD
Midazolam—Headache—Prednisone—ankylosing spondylitis	0.000239	0.000939	CcSEcCtD
Midazolam—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000235	0.000922	CcSEcCtD
Midazolam—Asthenia—Methotrexate—ankylosing spondylitis	0.000229	0.000898	CcSEcCtD
Midazolam—Nausea—Prednisone—ankylosing spondylitis	0.000226	0.00089	CcSEcCtD
Midazolam—Pruritus—Methotrexate—ankylosing spondylitis	0.000225	0.000886	CcSEcCtD
Midazolam—Dizziness—Methotrexate—ankylosing spondylitis	0.000211	0.000828	CcSEcCtD
Midazolam—GABRG3—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000204	0.0095	CbGpPWpGaD
Midazolam—Vomiting—Methotrexate—ankylosing spondylitis	0.000203	0.000796	CcSEcCtD
Midazolam—Rash—Methotrexate—ankylosing spondylitis	0.000201	0.000789	CcSEcCtD
Midazolam—Dermatitis—Methotrexate—ankylosing spondylitis	0.000201	0.000789	CcSEcCtD
Midazolam—GABRB1—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.0002	0.00936	CbGpPWpGaD
Midazolam—Headache—Methotrexate—ankylosing spondylitis	0.0002	0.000784	CcSEcCtD
Midazolam—GABRA6—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.00019	0.00885	CbGpPWpGaD
Midazolam—Nausea—Methotrexate—ankylosing spondylitis	0.000189	0.000744	CcSEcCtD
Midazolam—GABRA4—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000187	0.00874	CbGpPWpGaD
Midazolam—GABRB2—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000171	0.008	CbGpPWpGaD
Midazolam—GABRA1—SIDS Susceptibility Pathways—RUNX3—ankylosing spondylitis	0.000168	0.00786	CbGpPWpGaD
Midazolam—GABRA5—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000166	0.00777	CbGpPWpGaD
Midazolam—GABRA3—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000163	0.00763	CbGpPWpGaD
Midazolam—GABRA2—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000161	0.0075	CbGpPWpGaD
Midazolam—UGT1A4—Aryl Hydrocarbon Receptor Pathway—TNF—ankylosing spondylitis	0.00016	0.00747	CbGpPWpGaD
Midazolam—GABRB3—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.00016	0.00745	CbGpPWpGaD
Midazolam—GABRG2—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000157	0.00731	CbGpPWpGaD
Midazolam—GABRA1—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000137	0.00639	CbGpPWpGaD
Midazolam—SLC22A1—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000117	0.00547	CbGpPWpGaD
Midazolam—GABRA1—SIDS Susceptibility Pathways—IL1RN—ankylosing spondylitis	0.000116	0.00542	CbGpPWpGaD
Midazolam—ABCB1—Allograft Rejection—HLA-C—ankylosing spondylitis	0.000116	0.0054	CbGpPWpGaD
Midazolam—ABCB1—Allograft Rejection—IL17A—ankylosing spondylitis	0.000106	0.00494	CbGpPWpGaD
Midazolam—ABCB1—Allograft Rejection—IL12B—ankylosing spondylitis	9.83e-05	0.00459	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—B3GNT2—ankylosing spondylitis	8.72e-05	0.00407	CbGpPWpGaD
Midazolam—GABRA1—SIDS Susceptibility Pathways—IL1A—ankylosing spondylitis	8.37e-05	0.0039	CbGpPWpGaD
Midazolam—GABRA1—SIDS Susceptibility Pathways—IL10—ankylosing spondylitis	8.32e-05	0.00388	CbGpPWpGaD
Midazolam—ABCB1—Allograft Rejection—IL1A—ankylosing spondylitis	7.23e-05	0.00337	CbGpPWpGaD
Midazolam—ABCB1—Allograft Rejection—IL10—ankylosing spondylitis	7.19e-05	0.00336	CbGpPWpGaD
Midazolam—ABCB1—Allograft Rejection—CD40LG—ankylosing spondylitis	7.19e-05	0.00336	CbGpPWpGaD
Midazolam—ABCB1—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	6.87e-05	0.00321	CbGpPWpGaD
Midazolam—ABCB1—Allograft Rejection—HLA-B—ankylosing spondylitis	6.84e-05	0.00319	CbGpPWpGaD
Midazolam—ABCB1—Allograft Rejection—HLA-A—ankylosing spondylitis	6.34e-05	0.00296	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—B3GNT2—ankylosing spondylitis	5.45e-05	0.00255	CbGpPWpGaD
Midazolam—GABRA1—SIDS Susceptibility Pathways—TNF—ankylosing spondylitis	3.17e-05	0.00148	CbGpPWpGaD
Midazolam—ABCB1—Allograft Rejection—TNF—ankylosing spondylitis	2.74e-05	0.00128	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—B3GNT2—ankylosing spondylitis	2.63e-05	0.00123	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—B3GNT2—ankylosing spondylitis	2.45e-05	0.00114	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—B3GNT2—ankylosing spondylitis	1.95e-05	0.000909	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—B3GNT2—ankylosing spondylitis	1.91e-05	0.000891	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—B3GNT2—ankylosing spondylitis	1.9e-05	0.000889	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—B3GNT2—ankylosing spondylitis	1.44e-05	0.000671	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—ankylosing spondylitis	1.35e-05	0.00063	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—B3GNT2—ankylosing spondylitis	8.85e-06	0.000413	CbGpPWpGaD
